BlackDoctor12h
Are You at Risk? Health Conditions That Lead To EPI
Exocrine pancreatic insufficiency (EPI) occurs in chronic pancreatitis, cystic fibrosis, autoimmune disorders such as Crohn’s disease and systemic lupus erythematosus and patients that have had parts ...
thecardiologyadvisor.com15h
Lupus Does Not Affect Post-Acute Myocardial Infarction Outcomes
There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.
BMJ5d
Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K + CD8 T cell activation in lupus kidney
is a condition in which systemic lupus erythematosus (SLE) affects the kidney, causing inflammation and damage. Renal disease develops early in SLE, with up to two-thirds of patients progressing to LN ...
Cullinan’s CLN-978: A Promising Breakthrough in SLE Treatment Gains Buy Recommendation
Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of ...
marketinference6d
Cullinan Therapeutics FDA Cleared for CLN-978
The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...
Unique immune response in lupus paves the way for new treatments
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...
Cullinan Therapeutics Gets FDA Approval for Lupus Treatment Study
Cullinan Therapeutics said the U.S. Food and Drug Administration approved its investigation new drug application for CLN-978, a potential treatment for lupus. The biopharmaceutical company said the ...